Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Appointed CFO
Appointed director
|
|
RELMADA THERAPEUTICS, INC. (RLMD)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/09/2023 |
SC 13G
| VANGUARD GROUP INC reports a 5% stake in Relmada Therapeutics Inc. |
| 12/20/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 10/21/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 10/17/2022 |
SC 13G
| CITADEL ADVISORS LLC reports a 4.4% stake in Relmada Therapeutics, Inc. |
| 09/23/2022 |
SC 13G
| PERCEPTIVE ADVISORS LLC reports a 7% stake in Relmada Therapeutics, Inc. |
| 02/14/2022 |
SC 13G
| Venrock Healthcare Capital Partners II, L.P. reports a 8.2% stake in Relmada Therapeutics, Inc. |
| 12/20/2021 |
SC 13G
| BIOTECHNOLOGY VALUE FUND L P reports a 5.9% stake in Relmada Therapeutics, Inc. |
| 12/20/2021 |
SC 13G
| RA CAPITAL MANAGEMENT, L.P. reports a 7.2% stake in Relmada Therapeutics, Inc. |
| 02/12/2021 |
SC 13G
| Avoro Capital Advisors LLC reports a 9.4% stake in Relmada Therapeutics, Inc. |
| 02/02/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 06/11/2020 |
SC 13G
| RTW INVESTMENTS, LLC reports a 8.3% stake in Relmada Therapeutics, Inc. |
| 02/14/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 12/16/2019 |
SC 13G
| Venrock Healthcare Capital Partners II, L.P. reports a 6.2% stake in Relmada Therapeutics, Inc. |
| 10/31/2019 |
SC 13G
| TANG CAPITAL PARTNERS LP reports a 7.8% stake in Relmada Therapeutics, Inc. |
| 04/05/2019 |
SC 13G
| Wonpung Mulsan Co., Ltd. reports a 6% stake in RULE 13d2 RELMADA THERAPEUTICS, INC. |
| 10/31/2017 |
SC 13G
| KEMMERER JOHN L III reports a 8.7% stake in RULE 13d2. Relmada Therapeutics, Inc. |
| 10/11/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 11/23/2016 |
SC 13G
| Uh Eun Sun reports a 8.6% stake in RULE 13d2 RELMADA THERAPEUTICS, INC. |
| 06/24/2016 |
SC 13G
| Wonpung Mulsan Co., Ltd. reports a 6.1% stake in RULE 13d2 RELMADA THERAPEUTICS, INC. |
|
|